Similar to our observations in the rat model, EcN C6 treatment lowered the inflammatory response as reflected by the renal pathology HE section (Figure 5d) and kidney IL‐1β levels (Figure 5e). The gene discussed is IL1B; the disease is hereditary elliptocytosis.